Loblaw Companies Ltd (L.TO)
Investor Insights
Sep 12, 2026, 12:00 am This summary was created by AI, based on 10 opinions in the last 12 months.
Loblaw Companies Ltd is perceived as a defensive investment due to its dominant position as Canada's largest food and drug retailer. Many experts highlight the company's strong performance in recent years, driven by food inflation and acquisitions such as Shoppers Drug Mart, which has improved profitability and enhanced free cash flow. However, concerns about valuation persist, with some experts suggesting it may be overvalued relative to its growth prospects. The competitive landscape with major players like Walmart and Costco adds to the challenge, yet Loblaw's focus on private labels and discount banners is seen as a positive. Overall, while there are differing opinions, the common thread is a cautious approach to buying due to current pricing levels.
Loblaw Companies Ltd (L.TO) Frequently Asked Questions
What is Loblaw Companies Ltd stock symbol?
Loblaw Companies Ltd is a Canadian stock, trading under the symbol L.TO (previously L-T on Stockchase) on the Toronto Stock Exchange (L-CT). It is usually referred to as TSX:L or L.TO
Is Loblaw Companies Ltd a buy or a sell?
In the last year, 10 stock analysts issued a Buy, Sell, or Hold rating on L.TO (previously L-T on Stockchase). 4 analysts recommended to BUY and 4 analysts recommended to SELL the stock. The latest stock analyst rating is WEAK BUY. Read the latest stock experts' ratings for Loblaw Companies Ltd.
Is Loblaw Companies Ltd worth watching?
Loblaw Companies Ltd is followed by 322 investors on Stockchase and is a trending stock that is worth watching.
What is Loblaw Companies Ltd stock price?
On 2026-09-11, Loblaw Companies Ltd (L.TO) stock closed at a price of $61.28.